Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | MAOA | P21397 | 1/20 | 0.34 |
| ▸ | MAOB | P27338 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | F2 | P00734 | 1/20 | 0.33 |
| ▸ | F10 | P00742 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9315029 | 0.92 | KDM4E (0.40) | LMNAALDH1A1KDM4ETHRBTP53 | |
| SCHEMBL9315765 | 0.86 | TAS1R3 (0.41) | LMNAALDH1A1KDM4ETHRBTP53 | |
| SCHEMBL9316716 | 0.85 | ALDH1A1 (0.43) | LMNAALDH1A1KDM4ETHRBTP53 | |
| SCHEMBL9315905 | 0.84 | CA12 (0.42) | LMNAALDH1A1KDM4ETHRBTP53 | |
| SCHEMBL9315814 | 0.84 | TP53 (0.48) | LMNAALDH1A1KDM4ETHRBTP53 | |
| SCHEMBL9315934 | 0.84 | KDM4E (0.39) | LMNAALDH1A1KDM4ETHRBTP53 | |
| SCHEMBL9315775 | 0.80 | LMNA (0.36) | LMNAALDH1A1KDM4EMAPTCYP2C19 | |
| SCHEMBL482069 | 0.73 | MAPT (0.46) | LMNAALDH1A1KDM4EMAPTCYP2C19 | |
| SCHEMBL9315021 | 0.71 | KDM4E (0.38) | LMNAALDH1A1KDM4EMAPTCYP2C19 | |
| SCHEMBL9195312 | 0.71 | GAA (0.43) | LMNAALDH1A1THRBCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5278166-A | 4-amino-3-heteroaryl butyric acid compounds, compositions, and their use for treating disorders involving a dysfunction of GABAB receptors | ADIR ET COMPAGNIE (FR) | 1994-01-11 | — | — | US | disclosed |
| US-5214063-A | 4-aminobutyric acid compounds, compositions and methods of use for treating disorders related to a dysfunction of GABAB receptors | ADIR ET COMPAGNIE (FR) | 1993-05-25 | — | — | US | disclosed |
| US-5162364-A | Treatment of spastic and senescence disorders | ADIR ET COMPAGNIE (FR) | 1992-11-10 | — | — | US | disclosed |